GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (BOM:532878) » Definitions » Other Income (Expense)

Alpa Laboratories (BOM:532878) Other Income (Expense) : ₹149 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Alpa Laboratories Other Income (Expense)?

Alpa Laboratories's other income expense for the Alpa Laboratories's pretax income for the three months ended in Mar. 2024 was ₹40 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹149 Mil.

Alpa Laboratories Other Income (Expense) Historical Data

The historical data trend for Alpa Laboratories's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpa Laboratories Other Income (Expense) Chart

Alpa Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.55 4.94 87.82 99.33 148.90

Alpa Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.85 44.68 29.53 35.50 39.66

Alpa Laboratories Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹149 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpa Laboratories  (BOM:532878) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Alpa Laboratories (BOM:532878) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpa Laboratories Ltd (BOM:532878) » Definitions » Other Income (Expense)
Comparable Companies
BOM:524518 BOM:531173 BOM:537536 BOM:532637 NSE:VAISHALI BOM:524824 BOM:532384 BOM:530313 NSE:SOTAC BOM:540702 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ALPA:India
Address
33/2, A.B. Road, Pigdamber, Rau, Indore, MP, IND, 453446
Website
https://www.alpalabs.in
Alpa Laboratories Ltd is an India-based pharmaceutical company. It operates in the business segment of Drugs and Chemicals. The company manufactures and markets pharmaceuticals and related products. It sells products like liquid injection, dry powder injection, tablets, capsules, and ointments.

Alpa Laboratories (BOM:532878) Headlines

No Headlines